Mechanistically, experiments performed in pancreatic cancer cell lines have shown that gemcitabine treatment induces VMP1 expression [6,44] through a pathway involving the Transcription Factor E2F1 (E2F1), and EP300 ultimately triggering autophagy [6]. Here, E2F1 is linked to pancreatic neoplasm.